Specifications tableSubjectBiologySpecific subject areaDevelopmental biologyType of dataTable\
FigureHow data were acquiredSequencing of RNA from Rcho-1 rat trophoblast stem (TS) cellsData formatRaw (Fastq) and analyzed (Excel tables)Parameters for data collectionRNA-sequencing was performed on Rcho-1 cells treated with shRNAs against *Satb1* gene or control shRNA.Description of data collectionRcho-1 rat TS cells were stably transduced with lentivirus to deliver the shRNAs. Total RNAs were purified from the shRNA-transduced cells and analyzed by mRNA-sequencing. SATB1-regulated genes in Rcho-1 cells were identified by analyses of the transcriptome data using CLC Genomics Workbench.Data source locationUniversity of Kansas Medical Center, Kansas City, KS 66160, USAData accessibilityRepository name: SRA\
Data identification number: PRJNA558387\
Direct URL to data: <https://www.ncbi.nlm.nih.gov/sra>**Value of the Data**•This article provides with the transcriptome analyses of differentially expressed genes in Rcho-1 rat TS cells treated with shRNA targeted to *Satb1* gene.•These datasets represent the SATB1-target genes as well as the potential off-targets of the shRNAs.•These data can be used to identify the SATB1-regulated genes that maintain proliferation and inhibit differentiation of TS cells.

1. Data {#sec1}
=======

Transcriptome data generated by RNA-sequencing of Rcho-1 rat TS cells treated with shRNA targeted to *Satb1* or *Egfp* were analyzed to identify the differentially expressed genes. Analyzed data are presented in Excel format and the raw data are deposited to NCBI SRA (SRR9894784-9894789, included under PRJNA558387). SRR9894786 and SRR9894787 are raw data obtained from Rcho-1 cells treated with control shRNA (*Egfp*), whereas SRR9894784, SRR9894785, SRR9894788 and SRR9894789 are the raw data obtained from Rcho-1 cells treated with *Satb1* shRNA. Analyzed data are presented in the following tables:

[Supplementary Table 1](#appsec1){ref-type="sec"}. Differentially expressed genes in Rcho-1 rat TS cells treated with shRNA targeted to *Satb1* exon 9.

Transcriptome analyses of SATB1-regulated genes in Rcho-1 cells compared to control shRNA. Of the 3699 differentially expressed genes, 2462 were ≥2 fold upregulated, whereas the 1237 were ≤2 fold downregulated.

[Supplementary Table 2](#appsec1){ref-type="sec"}. Differentially expressed genes in Rcho-1 rat TS cells treated with shRNA targeted to *Satb1* exon 12.

Transcriptome analyses of SATB1-regulated genes in Rcho-1 cells compared to control shRNA. Of the 4265 differentially expressed genes, 2781 were ≥2 fold upregulated, whereas the 1484 were ≤2 fold downregulated.

[Supplementary Table 3](#appsec1){ref-type="sec"}. Differentially expressed genes in Rcho-1 rat TS cells treated with shRNA targeted to either *Satb1* exon 9 or exon 12.

Differentially expressed genes in Rcho-1 cells treated with shRNA targeted to *Satb1* exon 9 were compared with those of shRNA targeted to *Satb1* exon 12. Of the 3699 differentially expressed genes with shRNA targeted to *Satb1* exon 9, and 4265 differentially expressed genes with shRNA targeted to *Satb1* exon 12, 2447 were common to both groups.

[Supplementary Table 4](#appsec1){ref-type="sec"}. Differentially expressed unique genes in Rcho-1 rat TS cells treated with shRNA targeted to *Satb1* exon 9.

Differentially expressed genes in Rcho-1 cells treated with shRNA targeted to *Satb1* exon 9 were compared with those of shRNA targeted to *Satb1* exon 12. Of the 3699 differentially expressed genes with shRNA targeted to *Satb1* exon 9, 1252 were unique, which represent potential off-targets of the shRNA.

[Supplementary Table 5](#appsec1){ref-type="sec"}. Differentially expressed unique genes in Rcho-1 rat TS cells treated with shRNA targeted to *Satb1* exon 12.

Differentially expressed genes in Rcho-1 cells treated with shRNA targeted to *Satb1* exon 9 were compared with those of shRNA targeted to *Satb1* exon 12. Of the 4265 differentially expressed genes with shRNA targeted to *Satb1* exon 12, 1818 were unique, which represent potential off-targets of the shRNA.

2. Experimental design, materials and methods {#sec2}
=============================================

2.1. Culture of Rcho-1 cells {#sec2.1}
----------------------------

Rcho-1 rat TS cells were maintained in stem-state by culturing them in appropriate culture conditions as reported previously \[[@bib1],[@bib2]\].

2.2. Satb1 knockdown {#sec2.2}
--------------------

Rcho-1 cells were transduced with lentivirus carrying shRNA-encoding pLKO.1-puro vectors \[[@bib3]\]. Stably transduced cells were established by selection with puromycin for sustained knockdown of *Satb1* expression \[[@bib4]\]. Two effective *Satb1* shRNAs (shRNA targeted to exon 9 and exon 12) were used for the targeted knockdown \[[@bib4]\]. A shRNA targeted to *Egfp* was used as a non-targeted control \[[@bib4]\].

2.3. Purification of RNA, library preparation and RNA-sequencing {#sec2.3}
----------------------------------------------------------------

Total RNA was extracted from the shRNA transduced Rcho-1 cells using TRI Reagent (Sigma-Aldrich, St. Louis, MO) following the manufacturer\'s instruction. RNA quality was assessed by a Bioanalyzer, and samples with a RIN value over 9 were selected for mRNA-sequencing library preparation. Approximately 500 ng of total RNA was used for the RNA-sequencing library preparation using a TruSeq Standard mRNA kit (Illumina, San Diego, CA) following the manufacturer\'s instruction \[[@bib5]\]. Briefly, mRNA was first enriched from total RNA by oligo-dT magnetic beads and then purified and chemically fragmented. The first strand of cDNA was synthesized by using random hexamer primers and reverse transcriptase. Then double stranded cDNA (ds cDNA) was generated by removing the RNA template and then synthesizing a replacement strand, which incorporated dUTP instead of dTTP. ds cDNAs were purified using AMPure XP beads (Beckman Coulter, Brea, CA). The cDNA ends were blunted and a poly (A) tail was added to the 3′ ends. Finally, after ligation of index adapters (Illumina), the suitable DNA fragments were selected for 15 cycles of PCR amplification. Each cDNA library was prepared from pooling three RNA samples. Two replicated of cDNA libraries were prepared for each of the control (*Egfp*) and *Satb1* shRNA treated groups. The paired-end cDNA libraries were initially evaluated for quality and then sequenced on an Illumina HiSeq X sequencer with 2 x 100 cycles (Novogene Corporation, Sacramento, CA). [Fig. 1](#fig1){ref-type="fig"}.Fig. 1**Schematic presentation of the experimental design.** Rcho-1 rat TS cells were grown in proliferating condition. Cells were transduced with lentivirus encoding shRNAs, and stably transduced cells were selected by adding puromycin to Rcho-1 culture media. Total RNAs were extracted from the stably transduced cells, assessed by Bioanalyzer, and used for mRNA-sequencing. RNA-sequencing data were analyzed by using CLC Genomics Workbench.Fig. 1

2.4. RNA-seq data analyses {#sec2.4}
--------------------------

RNA-sequencing data were demultiplexed, trimmed, aligned and analyzed using CLC Genomics Workbench 12.2 (Qiagen Bioinformatics, Germantown, MD). Trimming was performed to remove the low-quality reads, and good-quality reads were aligned with *Rattus norvegicus* genome (Rnor_6.0) using default parameters: (a) maximum number of allowable mismatches was 2, (b) minimum length and similarity fraction was set at 0.8, and (c) minimum number of hits per read was 10. Expression values were measured in TPM (transcripts per million). The threshold *p*-value was determined according to the false discovery rate (FDR). Differentially expressed genes were determined if the absolute fold change in expression was 2 with an FDR *p*-value of ≤0.05.

2.5. Statistical analysis {#sec2.5}
-------------------------

Each RNA-sequencing library was prepared using pooled RNA samples from three independent culture samples. Each group of RNA-sequencing consisted of two libraries. Differentially expressed genes were identified by CLC Genomics Workbench as described previously \[[@bib5]\].
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